| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3654 | |||||||||||||||||||||||
| Submitter : | Mr. Jonathan Gazave | Date & Time: | 12/19/2006 09:12:42 | |||||||||||||||||||||
| Organization : | Mr. Jonathan Gazave | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I am writing to express my opposition to the use of any tissue from aborted fetuses in the manufacture of any medications, including vaccines. I believe there are serious ethical problems with this course of action and in the worse case, it may encourgage more abortions for the wrong reasons. Further, at a minimum, it should be policy to always offer alternative medications to those who have serious ethical concerns with medications or theraputic techniques which involve either the use of aborted fetuses or destructive embryonic stem cell lines. Thanks | ||||||||||||||||||||||||